dual energy x ray absorptiometry dxa device (Hologic Inc)
86
Structured Review
Hologic Inc
dual energy x ray absorptiometry dxa device
Dual Energy X Ray Absorptiometry Dxa Device, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dual+energy+x+ray+absorptiometry+dxa+equipment/absorptiometry+dual+energy+ray+x/pmc12672682-125-17-25
Average 86 stars, based on 1 article reviews
Dual Energy X Ray Absorptiometry Dxa Device, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dual+energy+x+ray+absorptiometry+dxa+equipment/absorptiometry+dual+energy+ray+x/pmc12672682-125-17-25
Average 86 stars, based on 1 article reviews
dual energy x ray absorptiometry dxa device - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
other:Article Title: Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study. Article Snippet: Purpose: To investigate the impact of baseline total N-terminal propeptide of procollagen (PINP) levels on increases in bone mineral density (BMD) after treatment with romosozumab (ROMO), teriparatide (TPTD), and denosumab (DMAb) in patients with treatment naïve primary osteoporosis.. Methods: This multicenter, retrospective cohort study included 462 treatment-naïve patients (88.7 % female; mean age, 75.5 years; baseline BMD T-scores: lumbar spine [LS], − 3.0; total hip [TH], − 2.7) who initiated treatment with ROMO (n = 310), TPTD (n = 70), or DMAb (n = 82).. Patients were stratified by baseline total PINP levels into low (≤ 70.1 μg/L) and high (> 70.1 μg/L) groups. |